Cheaper weight-loss drugs were expected to take off in India. But despite GLP-1s costing as little as $14 a month, demand has been slower than expected. From stigma to hesitant doctors, Satviki Sanjay explains why price isn’t the only barrier.
———-
Like this video? Subscribe https://www.youtube.com/@Bloomberg-News
Bloomberg News is the first word in business news. Visit bloomberg.com for the latest on global business, markets and more.
Get unlimited access to Bloomberg.com for $1.99/month for the first 3 months: https://www.bloomberg.com/subscriptions?in_source=YoutubeOriginals
Bloomberg on YouTube:
https://www.youtube.com/@business
https://www.youtube.com/@markets
https://www.youtube.com/@BloombergTechnology
https://www.youtube.com/@BloombergPodcasts
Connect with us on social:
https://www.instagram.com/bloombergbusiness
https://www.linkedin.com/company/bloomberg-news
@bloombergbusiness
https://www.facebook.com/bloombergbusiness